Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

Now, it’s worth noting Stock Advisor's total average return is 991% — a market-crushing outperformance compared to 195% for ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

A bespoke CRISPR base-editing therapy designed for a single infant with CPS1 deficiency has produced encouraging early ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family ...

CrisprBits has secured $3 Mn (INR 26.8 Cr) in a pre-Series A funding round led by Spectrum Impact and Rajendra Gogri's family ...